Simply laid out sides about hepatitis, in particular, hepatitis B as part of public health education that was presented to a mixture of the public and professionals.

1. Hit hepatitis B where it matters
Nimzing Ladep, MBBS, FWACP, PhD
Consultant, Hepatologist & Director (Worthy Works Medical
Education)

2. Public Education by Worthy Works Medical Education towards achieving the
goal of elimination of hepatitis B by 2030
What you need to know about
hepatitis B

3. Learning outcomes

4. At the end of this presentation, attendees will be able to
achieve the following:
Why hepatitis is important
Why you should care about
hepatitis
Know modes of transmission of
hepatitis B
Recognise some of the
symptoms and signs of hepatitis
B
Know treatment strategies for
hepatitis B
Recognise who qualifies for
treatment of hepatitis B
Learning outcomes

5. Importance of hepatitis
Reasons why you should pay attention to this information
1

6. 3
2
1
Hepatitis is defined as
inflammation of the
liver

7. 1
3
2
The liver is a vital
organ responsible for
- processing of
nutrients
- filtering blood
- fighting infections

8. 1
2
3
When inflamed, the
functions of the liver
are affected

15. How does hepatitis affect you?
You could be going about your business but chose to listen to this lecture. Why?
2

16. 01
Two billion people
are affected
globally
02
ho
,
e
03
04
05
"

17. Transmission of hepatitis B
Key to prevention is recognition of modes of transmission of disease.
3

18. Common modes of transmission of hepatitis B
01
Infected mother to
baby
02
Horizontal - among
children | family
members
03
Transfusion of infected
blood and blood
products
04
Use of infected unsterile
hospital equipment
05
Sharing of sharps -
razors, toothbrushes,
etc
06
Unprotected sexual
activity with an
infected person (if
they have a high viral
load)

26. Who are those at risk of hepatitis B?
Not everyone is at the same risk of hepatitis B – this is addressed in this presentation
4

27. 01 Babies of infected mothers
Those at risk of hepatitis B infection

28. 01 Babies of infected mothers
02 People who inject drugs
Those at risk of hepatitis B infection

29. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
Those at risk of hepatitis B infection

30. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
04 Men who have sex with men
Those at risk of hepatitis B infection

31. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
04 Men who have sex with men
05 Family members with an infected person
Those at risk of hepatitis B infection

32. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
04 Men who have sex with men
05 Family members with an infected person
06 Asians & Africans
Those at risk of hepatitis B infection

33. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
04 Men who have sex with men
05 Family members with an infected person
06 Asians & Africans
07 Commercial sex workers
Those at risk of hepatitis B infection

34. 01 Babies of infected mothers
02 People who inject drugs
03 Multiple sexual activities
04 Men who have sex with men
05 Family members with an infected person
06 Asians & Africans
07 Commercial sex workers
08 Those not vaccinated against HBV
Those at risk of hepatitis B infection

35. Symptoms & signs of hepatitis B
Recognising how hepatitis B presents could assist patients to seek care
5

36. Symptoms of Hepatitis B
virus infection

37. Most patients will
experience no symptoms Abdominal Pain

38. Jaundice – yellow eyes/skin
Dark urine

39. Nausea /vomiting
Fever

40. Loss of appetite/ Joint pains
Weakness and fatigue

41. Who qualifies for hepatitis B
treatment
Treatment of hepatitis B is not uniform for everyone – informed parameters are required
for decision making
6

42. Rest Proper
Nutrition
Plenty
fluids
Rarely, hospital
observation

43. Point
2
o All patients with chronic hepatitis B (CHB)
and clinical evidence of compensated or
decompensated cirrhosis (or cirrhosis
based on APRI score in adults) should be
treated, regardless of HBeAg status, ALT or
HBV DNA levels.

44. Point
2
All HIV-HBV co-infected
people are directly eligible
to Tenofovir-based
regimen for life included in
their HIV regimen.

45. Point
2
Treatment is also recommended for all
infants and adults (especially people aged
above 30 years) with CHB who do not
have clinical evidence of cirrhosis (or
based on APRI scores) and/or evidence
of high-level HBV replication (HBV DNA
>20 000 IU/mL)

46. • Several published eLearning resources on hepatitis and liver
diseases such as Liver Health App, Liver Nutrition, Hepatitis B
interactive, Hepatitis Nigeria Network – www.worthy-works.com

47. Thank
you